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Comparison between two distributions of dose was done by means of 
DVH’s of PTV, OAR and External phantom outline.  
Results: The volume of the smaller phantom was 6034 cm3 vs 6257 
cm3 of the modified volume of the bigger into the smaller (difference 
= 3.5%). Figure 1 shows the dosimetric comparison in terms of dvh’s 
between DD obtained by Velocity software and PD with Masterplan 
TPS. D98 for PTV was 94% and 97.5% for DD and PD; D50 was the same 
(100%) and D2 was 101% for DD as well as PD. Little bit difference was 
evident in the shape of DVH for OAR (Figure) even though no 
difference in terms of mean dose was found (1.22 Gy both for DD and 
PD). Also for external phantom volume (integral dose) the mean dose 
was similar (0.65 Gy for PD and 0.67 Gy for DD resulting in 3% of 
difference). 
Conclusions: By comparing the doses accumulated in the small 
phantom under the condition of deformation and the doses calculated 
with the treatment planning, this study has demonstrated the 
potential of validating an algorithm that include deformations into 
dose computation. Since only a very simple situation was explored, 
future investigations will focus more on the use of anthropomorphic 
phantom to simulate a real situation of deformable dose 
accumulation.  
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Purpose/Objective: To develop and validate an automated quality 
assurance software tool for the assessment and characterization of 
geometric distortion of MRI scanners commissioned for RT planning. 
Materials and Methods: A phantom and software platform that can be 
used to assess geometric accuracy for clinical MR applications that 
require large fields of view was developed. The phantom consists of 
357 rods (6 mm diameter) of polymethyl-methacrylat separated by 20 
mm intervals, providing a three dimensional array of control points at 
known spatial locations over a large field of view (total diameter of 
420mm). An in-house software module was developed to allow 
automatic geometric distortion assessment by: 1) segmentation of the 
rods in each image dataset, 2) calculation of rod positions, 3) 
correction of gross rotation errors due to phantom positioning during 
scanning and (4) comparison of corrected positions with a theoretical 
reference grid that simulates the known phantom geometry (ground 
truth). The software module was validated against a virtual CT 
dataset of the phantom that reproduced the exact geometry of the 
physical phantom, but with known translational and rotational 
displacements. The software module was then assessed using axial CT 
and MRI sequence datasets (2D T1/T2 FSE, 3D CUBE, T1 SPGR) 
acquired with application of a commercial 3D distortion correction 
algorithm (GradwarpTM). 
Results: For both virtual CT and CT validation experiments, the 
software robustly calculated rod positions within each axial dataset 
with sub-voxel accuracy. For the virtual phantom measurements, 
mean errors in the measured coordinates of the rod positions were in 
the order of 0.15mm, over the entire FOV. For CT, mean errors in the 
measured coordinates of the rod positions were in the order of 
0.23mm. For all MRI sequences, over a scan length of 15cm, mean 
geometric distortions (dxy) within a 10cm, 15cm, 20cm radius were 
found to be ≤0.5mm (range 0-1.9mm), < 0.6 mm (range 0-2.1mm) and 
< 0.7mm (range 0-2.8mm) respectively (with application of 
GradwarpTM). (Full data to be presented). 
Conclusions: A robust software module for the assessment and 
characterization of geometric distortion in MRI has been developed 
and validated. Our preliminary data suggests that this method may be 
a valuable tool for routine quality assurance for MRI applications that 
require stringent spatial accuracy assessment such as radiotherapy. 
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Purpose/Objective: The treatment workflow for IMRT head and neck 
patients includes a control CT at the third week of treatment. 
Velocity AI is a imaging software to display, register, and segment 
medical image volumes from multi-modality sources. It was 
introduced in our clinical practice in September 2011. The purpose of 
the present study was to evaluate the potentialities of deformable 
registration applied not just to anatomic structures but also to the 3D 
dose matrix in both image sets.  
Materials and Methods: The retrospective study included images, 
structures and dose data from five patients with H&N tumors treated 
with IMRT. The treatment planning was performed in Oncentra TPS 
(Nucletron/Elekta). Patient structures (PTVs and OARs) were 
delineated in Velocity AI 2.7. Three different image registration 
approaches were performed between the planning initial CT and the 
control CT image sets: 1) no region of interest (ROI) was defined for 
applying image registration; 2) a ROI was defined including the largest 
length of PTV in sagittal and coronal views (low and high risk 
lymphnodes) and 3) with a ROI involving each of the main OAR, like 
parotids, spinal cord, brainstem, mandible or tiroide. In all three 
options a rigid followed by a deformable registration was applied. The 
influence of the definition of a ROI on the deformed volume of the 
different OARs was studied. The OAR deformed structures were 
clinically evaluated by an experienced H&N radiation oncology who 
validated the second registration approach. Based on the validated 
deformed structure set a re-calculation of dose distribution was 
performed in Oncentra for the control CT and compared with the 
deformed dose matrix obtained with Velocity AI. 
Results: For a rigid structure like the mandible yet prone to positional 
errors, the volume difference between the three registrations was 2% 
(SD 3%) but the deformed volume differed in average 7% from the 
initially delineated structure. For the spinal cord no differences 
greater than 1% (SD 2%) were observed in volume. A systematic 
average shrinkage of 22% (SD 10%) for the parotid glands was observed 
between the initial and the control CTs, in line with similar results 
reported in literature. Concerning dose deformation in Velocity, 
underestimations of up to 7.8 Gy were obtained for the maximum 
dose in spinal cord when compared with re-calculation in Oncentra. 
Conclusions: The deformable image registration algorithm and 
available registration strategies in Velocity AI were tested for H&N 
clinical cases. The steps of the registration procedure for obtaining 
clinically valid deformed OARs were established. Concerning the 
available tool for 3D dose matrix deformation and using the results of 
this study we recommend additional caution, namely when tolerance 
dose for critical organs at risk is involved. Significant differences were 
obtained between the deformed dose in Velocity and the dose true 
calculation in Oncentra. 
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Purpose/Objective: The goal of traditional radiation therapy is to 
maximize absorbed dose in a target volume while minimizing the dose 
to normal, healthy tissue. This is especially challenging in the case of 
moving tumors due to breathing. 4DCT shows the extent of motion. In 
addition, it may allow the beam to be on during specific time intervals 
in the breathing cycle only (gating). However, 4D CT is prone to 
artifacts, possibly adversely affecting accuracy and hence treatment 
outcome of gated treatments.  
Materials and Methods: Measurements were done using a 16 slice 
General Electric Lightspeed CT with rotation time of 1 sec. The 
standard thorax imaging procedure, 2 mm slices and 120 kV, was used. 
Half and full rotation reconstructions were used when appropriate, 
reconstructing in 10 phases. Tests were performed using the 'Quasar 
phantom', using a polystyreen sphere in a wooden cylinder. 
Respiratory cycles varied between 0,1, 2, 3, 4, 5, and 6 seconds per 
breath, amplitudes between 0.5 cm and 2 cm, and 'breathing patterns' 
between sine and non-sine. Polystyreen sphere volumes, shapes, and 
locations were measured in each phase of the 4D images, and in the 
Maximum Intensity Projection (MIP) of the dataset. Results were 
compared to that of scans made in a more conventional way: the 'slow 
scan' and the 'helical scan'. Finally, the effects were assessed of 
alternative 4D scanning protocols and an improved algorithm for peak 
detection of the RPM system. 
